SS12 : Late-Breaking Clinical Trials

Updated:Nov 12,2013
web masthead-SS12 
 

Late-Breaking Clinical Trials

Sunday, Nov. 4, 2012Monday, Nov 5, 2012Tuesday, Nov. 6, 2012

LBCT.01: Practice Implications for CAD and VTE

LBCT.03: Treatments for Prevention of Cardiovascular Events: A Population Perspective

LBCT.05: Cell-Based Therapies for Myocardial Regeneration

LBCT.02: Health Economics and Quality of Life in Contemporary Trials

LBCT.04: Novel Treatments for Managing Lipid Disorders

LBCT.06: Management of LV Dysfunction: Devices and Drugs


 

Sunday, Nov. 4, 2012
LBCT.01: Practice Implications for CAD and VTE
ss12_Brighton-1
Tim Brighton
Prince of Wales Hospital
Sydney, Australia
 
Aspirin for The Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event: Results of the ASPIRE Randomized Controlled Trial
ss12_Montalescot-1
Gilles Montalescot

Pitié-Salpêtrière University Hospital
Paris, France
A Randomized Trial of Bedside Platelet Function Monitoring to Adjust Antiplatelet Therapy Versus Standard of Care in Patients Undergoing Drug Eluting Stent Implantation: The ARCTIC Study
ss12_Gurbal-1
Paul A Gurbel

Sinai Hospital Center for Thrombosis Research
Baltimore, Md. 
First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial - The TRILOGY ACS Platelet Function Sub-study
ss12_Lamas-1 
Gervasio A Lamas
Mount Sinai Medical Center
Miami, Fla.
Results of the Trial to Assess Chelation Therapy
ss12_Fuster-1
Valentin Fuster

Mount Sinai School of Medicine
New York, N.Y. 
Main Results of the Future REvascularization Evaluation in Patients with Diabetes Mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
 
Back to Top


LBCT.02: Health Economics and Quality of Life in Contemporary Trials
ss12_Porter-1
Thomas R Porter
University of Nebraska Medical Center
Omaha, NE
Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Exercise Echocardiography


ss12_Eisentein-1 
Eric L. Eisenstein
Duke Clinical Research Institute
Durham, NC
Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery
 ss12_Mark-1
Daniel B. Mark
Duke University Medical Center
Durham, NC
Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT)
 
ss12_Magnuson-1
Elizabeth A Magnuson
Saint Luke's Mid America Heart Institute
Kansas City, MO
Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial
Back to Top


Monday, Nov. 5, 2012
LBCT.03: Treatments for Prevention of Cardiovascular Events: A Population Perspective
ss12_alejandro macchia
Alejandro Macchia

Consorzio Mario Negri Sud
Santa Maria Imb, Italy
Omega-3 fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of a double-blind randomized clinical trial (FORWARD)
Presentation Slides  |  Summary Slide  |  Presentation Audio  |  Discussant Audio 
ss12_roberto marchioli
Roberto Marchioli

Consorzio Mario Negri Sud
Santa Maria Imbaro, Italy 
Fish Oil for the Prevention of Post-Operative Atrial Fibrillation - The Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial
Presentation Slides  |  Summary Slide  |  Presentation Audio  |  Discussant Audio   

Howard D Sesso
Brigham and Womens Hospital
Boston, MA
A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II
Presentation Slides | Summary Slide  
Simon A Thom
Imperial Coll London
London, United Kingdom 
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE)
Summary Slide  
Back to Top


LBCT.04: Novel Treatments for Managing Lipid Disorders
ss12_jay horton
Jay Horton
Dallas, TX
Overview of PCSK9 Inhibition in the Treatment of Hyperlipidemia
Presentation Slides
ss12_frederick real
 Frederick Raal
Universotu of Witwatersrand Johannisburg
South Africa
Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Presentation Slides | Summary Slide 
ss12_evan stein
 Evan Stein
Metabolic and Atherosclerosis Research Center Cincinnati, OH
Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects (GAUSS): Interim Results from a Randomized, Double-blind, Placebo-controlled Study
Summary Slide 
ss12_barry gumbiner
 Barry Gumbiner
Pfizer, Inc.
San Diego, CA
Effects of 12 Weeks of Treatment with RN316 (PF-04950615), a Humanized IgG2Δa Monoclonal Antibody Binding Proprotein Convertase Subtilisin Kexin Type 9, in Hypercholesterolemic Subjects on High and Maximal Dose Statins
Summary Slide 
ss12_gregory g schwartz
Gregory G Schwartz

VA Medical Center and University of Colorado
Denver, CO 
Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome
Presentation Slides | Summary Slide 
Back to Top


Tuesday, Nov. 6, 2012
LBCT.05: Cell-Based Therapies for Myocardial Regeneration
ss12_Dimmeler_Image
Stefanie Dimmeler
Frankfurt, Germany
Overview of the Field of Cell-based Therapies for Myocardial Regeneration
Presentation Slides 
ss12_Surder
Daniel Sürder

Fondazione Cardiocentro Ticino
Lugano, Switzerland
Results of the Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (Swiss Ami) Trial 
Presentation Slides | Summary Slide
ss12_Takehara
Naofumi Takehara

Kyoto Prefectual University of Medicine
Kyoto, Japan 
The ALCADIA (Autologous Human Cardiac-derived Stem Cell To Treat Ischemic Cardiomyopathy) Trial
Summary Slide
ss12_Traverse
Jay H Traverse

Minneapolis Heart Institute at Abbott Northwestern Hospital
Minneapolis, MN

The Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarction: The NHLBI and CCTRN TIME Trial
Summary Slide

ss12_Hare
Joshua M Hare

University of Miami School of Medicine
Miami, FL 
Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy (Posiedon)
Presentation Slides | Summary Slide
ss12_Bolli
Roberto Bolli

University of Louisville
Louisville, KY 
Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Interim Results of the SCIPIO Trial Up to 2 Years After Therapy
Summary Slide
Back to Top

LBCT.06: Management of LV Dysfunction: Devices and Drugs
ss12_Moss
Arthur J. Moss

Univ of Rochester Medical Ctr, Rochester, NY
MADIT Randomized Trial to Reduce Inappropriate Therapy (MADIT-RIT)
Summary Slide
ss12_Curtis
Anne B. Curtis

University at Buffalo
Buffalo, NY 
Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK HF Study)
Presentation Slides | Summary Slide
ss12_Lopez-de-Sa
Esteban Lopez-de-Sa

Hosp Univrio La Paz Madrid, Spain 
Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Hospital Cardiac Arrest
Summary Slide  
ss12_Teerlink 
John R Teerlink
San Francisco VAMC UCSF
San Francisco, CA
The RELAXin in Acute Heart Failure (RELAX-AHF) Trial
Summary Slide
ss12_Bart
 Bradley A Bart
Hennepin County Medical Center
Minneapolis, MN
Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network
Summary Slide
Back to Top

 


Connect with AHA Science News

twitter_FollowAHAScience
fb_LikeAHAScienceNews

Network with over 31,000 Heart and Stroke Professionals

DS-5610 PON Banner 280X137
  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org

Scientific Sessions Daily News

  • ss12_dailyNews_saturday.jpg
  • ss12_dailyNews_sunday.jpg
  • ss12_Daily News Monday
  • SS 12 Daily News Image - Tuesday
  • SS 12 Daily News Image - Wednesday

Sessions Daily News - Wednesday

Science News: Why I Subscribe

  • ss11_sn_gordontomaselli
  • ss11_sn_RobertHarrington
  • ss11_sn_elliottantman
  • ss11_sn_mikhailkosiborod

Why I Subscribe to Science News: Mikhail Kosiborod, MD, FAHA

Become A Member

MembershipBanner_Generic

Join or renew your AHA/ASA Professional Membership to qualify for members-only awards, and:

• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
• Enjoy much more.

Promo code: WDJ008ZZ